This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1984:15:199-212.

Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises

R Cabannes, J Lonsdorfer, J P Castaigne, A Ondo, A Plassard, I Zohoun

PMID: 6385647

Clinical Trial

Clinical and biological double-blind-study of ticlopidine in preventive treatment of sickle-cell disease crises

R Cabannes et al. Agents Actions Suppl. 1984.

. 1984:15:199-212.

Authors

R Cabannes, J Lonsdorfer, J P Castaigne, A Ondo, A Plassard, I Zohoun

PMID: 6385647

No abstract available

PubMed Disclaimer

Similar articles

A double-blind trial of ticlopidine in sickle cell disease.
Semple MJ, Al-Hasani SF, Kioy P, Savidge GF. Semple MJ, et al. Thromb Haemost. 1984 Jul 29;51(3):303-6. Thromb Haemost. 1984. PMID: 6388012 Clinical Trial.
Overview: clinical experiences with ticlopidine.
Day HJ. Day HJ. Agents Actions Suppl. 1984;15:297-309. Agents Actions Suppl. 1984. PMID: 6385654 Review. No abstract available.
Beneficial effects of ticlopidine on cardiopulmonary function of sickle cell patients not in crisis.
Lonsdorfer J, Castaigne JP, Lenormand E, Otayeck A, Bogui P, Dosso Y, Cabannes R. Lonsdorfer J, et al. Agents Actions Suppl. 1984;15:213-8. Agents Actions Suppl. 1984. PMID: 6592944 No abstract available.
The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study.
Tohgi H. Tohgi H. Agents Actions Suppl. 1984;15:279-82. Agents Actions Suppl. 1984. PMID: 6385652 Clinical Trial. No abstract available.
Hydroxyurea in the treatment of sickle-cell anemia.
Howard LW, Kennedy LD. Howard LW, et al. Ann Pharmacother. 1997 Nov;31(11):1393-6. Ann Pharmacother. 1997. PMID: 9391697 Review.

See all similar articles

Cited by

Population Pharmacokinetics/Pharmacodynamics of Ticagrelor in Children with Sickle Cell Disease.
Amilon C, Niazi M, Berggren A, Åstrand M, Hamrén B. Amilon C, et al. Clin Pharmacokinet. 2019 Oct;58(10):1295-1307. doi: 10.1007/s40262-019-00758-0. Clin Pharmacokinet. 2019. PMID: 30972696 Clinical Trial.
A pilot study of eptifibatide for treatment of acute pain episodes in sickle cell disease.
Desai PC, Brittain JE, Jones SK, McDonald A, Wilson DR, Dominik R, Key NS, Parise LV, Ataga KI. Desai PC, et al. Thromb Res. 2013 Sep;132(3):341-5. doi: 10.1016/j.thromres.2013.08.002. Epub 2013 Aug 8. Thromb Res. 2013. PMID: 23973010 Free PMC article. Clinical Trial.
Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders.
McTavish D, Faulds D, Goa KL. McTavish D, et al. Drugs. 1990 Aug;40(2):238-59. doi: 10.2165/00003495-199040020-00006. Drugs. 1990. PMID: 2226215 Review.
Role of the hemostatic system on sickle cell disease pathophysiology and potential therapeutics.
Pakbaz Z, Wun T. Pakbaz Z, et al. Hematol Oncol Clin North Am. 2014 Apr;28(2):355-74. doi: 10.1016/j.hoc.2013.11.011. Epub 2014 Jan 18. Hematol Oncol Clin North Am. 2014. PMID: 24589271 Free PMC article. Review.
The challenge of clinical end points in sickle cell disease.
Ataga KI. Ataga KI. Blood. 2023 Dec 14;142(24):2047-2054. doi: 10.1182/blood.2023021220. Blood. 2023. PMID: 37890140 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information